Cell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus

Retrovirology

Volumn 7, Issue , 2010, Pages

  Zhang, Xian Yang ^a,b   Kutner, Robert H ^a   Bialkowska, Agnieszka ^a,c   Marino, Michael P ^d   Klimstra, William B ^e   Reiser, Jakob ^a,d  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GLYCOPROTEIN E2; HYBRID PROTEIN; LENTIVIRUS VECTOR; LIGAND; STEM CELL FACTOR RECEPTOR; THROMBOSPONDIN; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN;

ARTICLE; AVIAN SARCOMA VIRUS; CELL INTERACTION; CELL SPECIFICITY; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; LEUKEMIA VIRUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SINDBIS VIRUS; STEM CELL; TARGET CELL; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS STRAIN; AMINO ACID SEQUENCE; CELL LINE; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; LENTIVIRINAE; METHODOLOGY; MOLECULAR GENETICS; PHYSIOLOGY; VIRAL TROPISM; VIRUS ENTRY;

AVES; SINDBIS VIRUS; SUBGROUP A; VESICULAR STOMATITIS VIRUS;

AMINO ACID SEQUENCE; AVIAN SARCOMA VIRUSES; CELL LINE; GENE THERAPY; GENETIC VECTORS; HUMANS; LENTIVIRUS; MOLECULAR SEQUENCE DATA; SINDBIS VIRUS; TRANSDUCTION, GENETIC; VESICULOVIRUS; VIRAL FUSION PROTEINS; VIRAL TROPISM; VIRUS INTERNALIZATION;

EID: 76949094417     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-3     Document Type: Article

References (52)

1. Waehler R, Russell SJ, Curiel DT. Engineering targeted viral vectors for gene therapy. Nat Rev Genet 2007, 8:573-587. 10.1038/nrg2141, 17607305.
2. Cronin J, Zhang XY, Reiser J. Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 2005, 5:387-398. 10.2174/1566523054546224, 1368960, 16101513.
3. Frecha C, Szecsi J, Cosset FL, Verhoeyen E. Strategies for targeting lentiviral vectors. Curr Gene Ther 2008, 8:449-460. 10.2174/156652308786848003, 19075628.
4. Morizono K, Bristol G, Xie YM, Kung SK, Chen IS. Antibody-directed targeting of retroviral vectors via cell surface antigens. J Virol 2001, 75:8016-8020. 10.1128/JVI.75.17.8016-8020.2001, 115045, 11483746.
5. Morizono K, Chen IS. Targeted gene delivery by intravenous injection of retroviral vectors. Cell Cycle 2005, 4:854-856.
6. Morizono K, Xie Y, Ringpis GE, Johnson M, Nassanian H, Lee B, Wu L, Chen IS. Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat Med 2005, 11:346-352. 10.1038/nm1192, 15711560.
7. Morizono K, Ringpis GE, Pariente N, Xie Y, Chen IS. Transient low pH treatment enhances infection of lentiviral vector pseudotypes with a targeting Sindbis envelope. Virology 2006, 355:71-81. 10.1016/j.virol.2006.07.015, 16905172.
8. Pariente N, Morizono K, Virk MS, Petrigliano FA, Reiter RE, Lieberman JR, Chen IS. A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration. Mol Ther 2007, 15:1973-1981. 10.1038/sj.mt.6300271, 17653099.
9. Pariente N, Mao S-H, Morizono K, Chen ISY. Efficient targeted transduction of primary human endothelial cells with dual-targeted lentiviral vectors. The Journal of Gene Medicine 2008, 10:242-248. 10.1002/jgm.1151, 18074400.
10. Morizono K, Xie Y, Helguera G, Daniels TR, Lane TF, Penichet ML, Chen ISY. A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide. The Journal of Gene Medicine 2009, 11:655-663. 10.1002/jgm.1345, 19455593.
11. Morizono K, Pariente N, Xie Y, Chen ISY. Redirecting lentiviral vectors by insertion of integrin-tageting peptides into envelope proteins. The Journal of Gene Medicine 2009, 11:549-558. 10.1002/jgm.1339, 19434609.
12. Liang M, Pariente N, Morizono K, Chen ISY. Targeted transduction of CD34+ hematopoietic progenitor cells in nonpurified human mobilized peripheral blood mononuclear cells. The Journal of Gene Medicine 2009, 11:185-196. 10.1002/jgm.1290, 19152374.
13. Liang M, Morizono K, Pariente N, Kamata M, Lee B, Chen ISY. Targeted Transduction via CD4 by a Lentiviral Vector Uses a Clathrin-Mediated Entry Pathway. J Virol 2009, 83:13026-13031. 10.1128/JVI.01530-09, 19793825.
14. Zhang K, Moussavi M, Kim C, Chow E, Chen IS, Fazli L, Jia W, Rennie PS. Lentiviruses with trastuzumab bound to their envelopes can target and kill prostate cancer cells. Cancer Gene Ther 2009, 16:820-831. 10.1038/cgt.2009.28, 19373278.
15. Aires da Silva F, Costa MJ, Corte-Real S, Goncalves J. Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies. Hum Gene Ther 2005, 16:223-234. 10.1089/hum.2005.16.223, 15761262.
16. Chandrashekran A, Gordon MY, Casimir C. Targeted retroviral transduction of c-kit+ hematopoietic cells using novel ligand display technology. Blood 2004, 104:2697-2703. 10.1182/blood-2003-10-3717, 15256424.
17. Yang L, Bailey L, Baltimore D, Wang P. Targeting lentiviral vectors to specific cell types in vivo. Proc Natl Acad Sci USA 2006, 103:11479-11484. 10.1073/pnas.0604993103, 1518805,1518805, 16864770.
18. Ziegler L, Yang L, Joo K, Yang H, Baltimore D, Wang P. Targeting lentiviral vectors to antigen-specific immunoglobulins. Hum Gene Ther 2008, 19:861-872. 10.1089/hum.2007.149, 2599792, 18590376.
19. Yang L, Yang H, Rideout K, Cho T, Joo KI, Ziegler L, Elliot A, Walls A, Yu D, Baltimore D, Wang P. Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat Biotechnol 2008, 26:326-334. 10.1038/nbt1390, 2366162, 18297056.
20. Joo KI, Wang P. Visualization of targeted transduction by engineered lentiviral vectors. Gene Ther 2008, 15:1384-1396. 10.1038/gt.2008.87, 2575058, 18480844.
21. Lei Y, Joo K-I, Wang P. Engineering fusogenic molecules to achieve targeted transduction of enveloped lentiviral vectors. Journal of Biological Engineering 2009, 3:8. 10.1186/1754-1611-3-8, 2698826, 19490632.
22. Froelich S, Ziegler L, Stroup K, Wang P. Targeted gene delivery to CD117-expressing cells in vivo with lentiviral vectors co-displaying stem cell factor and a fusogenic molecule. Biotechnology and Bioengineering 2009, 104:206-215. 10.1002/bit.22378, 19452500.
23. Snitkovsky S, Young JA. Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein. Proc Natl Acad Sci USA 1998, 95:7063-7068. 10.1073/pnas.95.12.7063, 22739, 9618539.
24. Boerger AL, Snitkovsky S, Young JA. Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types. Proc Natl Acad Sci USA 1999, 96:9867-9872. 10.1073/pnas.96.17.9867, 22302, 10449786.
25. Snitkovsky S, Niederman TM, Carter BS, Mulligan RC, Young JA. A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor. J Virol 2000, 74:9540-9545. 10.1128/JVI.74.20.9540-9545.2000, 112384, 11000224.
26. Snitkovsky S, Niederman TM, Mulligan RC, Young JA. Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein. J Virol 2001, 75:1571-1575. 10.1128/JVI.75.3.1571-1575.2001, 114065, 11152532.
27. Snitkovsky S, Young JA. Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein. Virology 2002, 292:150-155. 10.1006/viro.2001.1314, 11878917.
28. Robison CS, Whitt MA. The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly. J Virol 2000, 74:2239-2246. 10.1128/JVI.74.5.2239-2246.2000, 111705, 10666254.
29. Jeetendra E, Robison CS, Albritton LM, Whitt MA. The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion. J Virol 2002, 76:12300-12311. 10.1128/JVI.76.23.12300-12311.2002, 136858, 12414970.
30. Ryman KD, Gardner CL, Burke CW, Meier KC, Thompson JM, Klimstra WB. Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses. J Virol 2007, 81:3563-3573. 10.1128/JVI.02494-06, 1866052, 17215278.
31. Chandrashekran A, Gordon MY, Darling D, Farzaneh F, Casimir C. Growth factor displayed on the surface of retroviral particles without manipulation of envelope proteins is biologically active and can enhance transduction. J Gene Med 2004, 6:1189-1196. 10.1002/jgm.625, 15468194.
32. Klimstra WB, Ryman KD, Johnston RE. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol 1998, 72:7357-7366. 109960, 9696832.
33. Turner AM, Bennett LG, Lin NL, Wypych J, Bartley TD, Hunt RW, Atkins HL, Langley KE, Parker V, Martin F, et al. Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines. Blood 1995, 85:2052-2058.
34. Knauss DJ, Young JA. A fifteen-amino-acid TVB peptide serves as a minimal soluble receptor for subgroup B avian leukosis and sarcoma viruses. J Virol 2002, 76:5404-5410. 10.1128/JVI.76.11.5404-5410.2002, 137033, 11991969.
35. Funke S, Maisner A, Muhlebach MD, Koehl U, Grez M, Cattaneo R, Cichutek K, Buchholz CJ. Targeted cell entry of lentiviral vectors. Mol Ther 2008, 16:1427-1436. 10.1038/mt.2008.128, 18578012.
36. McKnight KL, Simpson DA, Lin SC, Knott TA, Polo JM, Pence DF, Johannsen DB, Heidner HW, Davis NL, Johnston RE. Deduced consensus sequence of Sindbis virus strain AR339: mutations contained in laboratory strains which affect cell culture and in vivo phenotypes. J Virol 1996, 70:1981-1989. 190027, 8627724.
37. Lewis BC, Chinnasamy N, Morgan RA, Varmus HE. Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector. J Virol 2001, 75:9339-9344. 10.1128/JVI.75.19.9339-9344.2001, 114502, 11533197.
38. Melikyan GB, Barnard RJ, Markosyan RM, Young JA, Cohen FS. Low pH is required for avian sarcoma and leukosis virus Env-induced hemifusion and fusion pore formation but not for pore growth. J Virol 2004, 78:3753-3762. 10.1128/JVI.78.7.3753-3762.2004, 371058, 15016895.
39. Delos SE, Godby JA, White JM. Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation. J Virol 2005, 79:3488-3499. 10.1128/JVI.79.6.3488-3499.2005, 1075726, 15731243.
40. Balliet JW, Gendron K, Bates P. Mutational analysis of the subgroup A avian sarcoma and leukosis virus putative fusion peptide domain. J Virol 2000, 74:3731-3739. 10.1128/JVI.74.8.3731-3739.2000, 111882, 10729148.
41. Bates P, Young JA, Varmus HE. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell 1993, 74:1043-1051. 10.1016/0092-8674(93)90726-7, 8402880.
42. Brojatsch J, Naughton J, Rolls MM, Zingler K, Young JA. CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell 1996, 87:845-855. 10.1016/S0092-8674(00)81992-3, 8945512.
43. Wen D, Boissel JP, Tracy TE, Gruninger RH, Mulcahy LS, Czelusniak J, Goodman M, Bunn HF. Erythropoietin structure-function relationships: high degree of sequence homology among mammals. Blood 1993, 82:1507-1516.
44. Langley KE, Mendiaz EA, Liu N, Narhi LO, Zeni L, Parseghian CM, Clogston CL, Leslie I, Pope JA, Lu HS, et al. Properties of variant forms of human stem cell factor recombinantly expressed in Escherichia coli. Arch Biochem Biophys 1994, 311:55-61. 10.1006/abbi.1994.1208, 7514387.
45. Cheng L, Du C, Murray D, Tong X, Zhang YA, Chen BP, Hawley RG. A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells. Gene Ther 1997, 4:1013-1022. 10.1038/sj.gt.3300507, 9415306.
46. Gomez MC, Pope CE, Kutner RH, Ricks DM, Lyons LA, Ruhe MT, Dumas C, Lyons J, Dresser BL, Reiser J. Generation of domestic transgenic cloned kittens using lentivirus vectors. Cloning Stem Cells 2009, 11:167-176. 10.1089/clo.2008.0054, 19203232.
47. Ricks DM, Kutner R, Zhang XY, Welsh DA, Reiser J. Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev 2008, 17:441-450. 10.1089/scd.2007.0194, 18513160.
48. Kuroda H, Kutner RH, Bazan NG, Reiser J. A comparative analysis of constitutive and cell-specific promoters in the adult mouse hippocampus using lentivirus vector-mediated gene transfer. J Gene Med 2008, 10:1163-1175. 10.1002/jgm.1249, 18773500.
49. Zhang XY, La Russa VF, Reiser J. Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins. J Virol 2004, 78:1219-1229. 10.1128/JVI.78.3.1219-1229.2004, 321376, 14722277.
50. Kutner RH, Zhang XY, Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 2009, 4:495-505. 10.1038/nprot.2009.22, 19300443.
51. Zhang XY, La Russa VF, Bao L, Kolls J, Schwarzenberger P, Reiser J. Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. Mol Ther 2002, 5:555-565. 10.1006/mthe.2002.0585, 11991746.
52. Zhang XY, Dinh A, Cronin J, Li SC, Reiser J. Cellular uptake and lysosomal delivery of galactocerebrosidase tagged with the HIV Tat protein transduction domain. J Neurochem 2008, 104:1055-1064. 10.1111/j.1471-4159.2007.05030.x, 17986221.